CytomX Therapeutics Free Cash Flow (Quarterly) Analysis

CytomX Therapeutics Inc (CTMX)

1.60 -0.03 (-1.84%) USD | NASDAQ | Apr 25, 16:00

1.57 -0.03 (-1.88%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-22.23M
September 30, 2023	-18.25M
June 30, 2023	-25.70M
March 31, 2023	9.301M
December 31, 2022	-1.575M
September 30, 2022	-34.26M
June 30, 2022	-34.65M
March 31, 2022	-42.05M
December 31, 2021	-31.44M
September 30, 2021	-29.97M
June 30, 2021	-28.31M
March 31, 2021	-30.92M
December 31, 2020	-17.87M
September 30, 2020	-25.46M
June 30, 2020	97.06M
March 31, 2020	-50.79M
December 31, 2019	-30.18M
September 30, 2019	-23.95M

Date	Value
June 30, 2019	-48.98M
March 31, 2019	-40.86M
December 31, 2018	-29.86M
September 30, 2018	-6.601M
June 30, 2018	-27.48M
March 31, 2018	-15.36M
December 31, 2017	21.77M
September 30, 2017	-5.795M
June 30, 2017	172.87M
March 31, 2017	-20.03M
December 31, 2016	1.334M
September 30, 2016	-15.04M
June 30, 2016	15.37M
March 31, 2016	-5.867M
December 31, 2015	-8.351M
September 30, 2015	-8.129M
June 30, 2015	-6.905M
March 31, 2015	-5.624M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-50.79M

Minimum

Mar 2020

97.06M

Maximum

Jun 2020

-20.54M

Average

-28.31M

Median

Jun 2021

Free Cash Flow (Quarterly) Benchmarks